Dalbavancin for treating prosthetic joint infections caused by Gram-positive bacteria: A proposal for a low dose strategy. A retrospective cohort study

BACKGROUND: Gram-positive bacteria are the leading cause of prosthetic joint infection (PJI). Dalbavancin is a lipoglycopeptide with remarkable pharmacokinetic properties and high bactericidal activity against most Gram-positive bacteria. Although clear evidence regarding its effectiveness in bone a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Rev Esp Quimioter
Autors principals: Martín, Luis Buzón, Fernández, María Mora, Perales Ruiz, Jose Manuel, Lafont, Maria Ortega, Paredes, Ledicia Álvarez, Morán Rodríguez, Miguel Ángel, Regueras, María Fernández, Machín Morón, Maria Ángeles, Lobón, Gregoria Mejías
Format: Artigo
Idioma:Inglês
Publicat: Sociedad Española de Quimioterapia 2019
Matèries:
Original
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6913079/
https://ncbi.nlm.nih.gov/pubmed/31642637
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars